CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 28 enrolled
Drug / intervention
Etravirinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00871234
NCT00871234Phase 1Completed
CompareCT.gov

Effects of Etravirine (INTELENCETM) on Endothelial Function in HIV-uninfected Adults: A Pilot Study

Indiana University·interventional·Posted Mar 30, 2009·Updated Jan 7, 2011

In Brief

A Phase 1 clinical trial evaluating Etravirine for Endothelial Function and 4 related conditions. Completed, enrolled 28 participants across 1 site.

Detailed Summary

The purpose of this study is to determine the safety and effects of etravirine, an HIV antiretroviral medication, on vascular function.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEndothelial Function, Lipids, Insulin Resistance, Inflammation, HIV Infections
CountriesUnited States
CollaboratorsTibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA

Timeline

Phase 1CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedMar 30, 2009
Enrollment StartApr 1, 2009
Primary CompletionMar 1, 2010
Study CompletionJul 1, 2010
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 17.3 years ago

Interventions

Etravirinedrug

Two one-hundred mg tablets orally twice daily for four weeks